ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation.

Omid Tavassoly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.